Subsequently, proteomics patterns that were developed using machine learning algorithms in a form of a 19-biomarker model (19-BM) were developed to discriminate csPCa (GS ≥ 7) from slow-progressing PCa in patients with low PSA levels (< 15 ng/ml) [13]. The gene discussed is KLK3; the disease is posterior cortical atrophy.